Copyright
©The Author(s) 2021.
World J Clin Cases. May 16, 2021; 9(14): 3252-3264
Published online May 16, 2021. doi: 10.12998/wjcc.v9.i14.3252
Published online May 16, 2021. doi: 10.12998/wjcc.v9.i14.3252
Characteristics | Lupus (n = 397935) | Ankylosing Spondylitis (n = 39250) | Sjogren syndrome (n = 114885) | Dermato-polymyositis (n = 30400) | Scleroderma (n = 69865) | Rheumatoid arthritis (n = 1249979) | Gout (n = 1953389) | Reactive arthritis (n = 5690) | Psoriaticarthritis (n = 87110) | Pseudogout (n = 43375) | Polymyalgia rheumatica (n = 172655) | Enteropathic arthritis (n = 935) | Vasculitis (n = 47125) |
Age, yr, mean ± SD | 52.1 ± 16.9 | 60.2 ± 16.2 | 64 ± 15.5 | 60.6 ± 16.5 | 62.6 ± 14.4 | 67.2 ± 14.2 | 70.5 ± 12.9 | 54.8 ± 17.9 | 60.8 ± 13.9 | 75.4 ± 12.1 | 79.1 ± 9.4 | 45.6 ± 17.4 | 60.9 ± 16.3 |
Gender | |||||||||||||
Male | 11.5% | 65.1% | 8.4% | 31.5% | 15.5% | 26% | 67.5% | 63.3% | 42.8% | 48.5% | 31.7% | 37.9% | 47.5% |
Female | 88.5% | 34.9% | 91.5% | 68.5% | 84.5% | 74% | 32.5% | 36.7% | 57.2% | 51.4% | 68.3% | 62% | 52.5% |
Elixhauser Comorbidities | |||||||||||||
Afib. | 9.9% | 14.7% | 14.7% | 16.5% | 17.3% | 18.9% | 30.2% | 12% | 14.7% | 27.1% | 33.2% | 3.2% | 18.2% |
Coronary Arterial Disease | 17.9% | 21.5% | 18.9% | 21.7% | 22.5% | 25.8% | 38.7% | 16.1% | 21.6% | 28.6% | 35.3% | 7.5% | 22.7% |
Congestive heart failure | 12.8% | 10.1% | 11% | 14.2% | 17.7% | 14.1% | 21.1% | 8.6% | 8.8% | 15.5% | 18.5% | 5.3% | 15.7% |
Obstructive sleep apnea | 7.4% | 11.1% | 10.2% | 9.4% | 7.8% | 9.7% | 16.4% | 8.6% | 14.7% | 7.8% | 11.2% | 6.4% | 9.4% |
Valvular disease | 4% | 3.5% | 4.7% | 3.5% | 5.5% | 4.4% | 5% | 2.7% | 3.2% | 7.1% | 7.5% | 0.5% | 4.3% |
Chronic pulmonary disease | 22.3% | 19.3% | 24.2% | 18.7% | 23.1% | 27.8% | 22.8% | 17.9% | 21.9% | 18.5% | 23.2% | 17.6% | 28.2% |
Hypertension | 53.4% | 52.7% | 51.6% | 53.9% | 50.8% | 61.1% | 69.4% | 44.8% | 58.2% | 68.9% | 67.6% | 26.7% | 58.4% |
Diabetes w/o chronic complications | 8.9% | 11.7% | 8.5% | 14,5% | 6.8% | 12.9% | 15.9% | 7.9% | 13.5% | 12.6% | 12.6% | 9.1% | 8.6% |
Diabetes w/ chronic complications | 9.7% | 10.6% | 8% | 13.4% | 7% | 12.1% | 23% | 10.7% | 14.4% | 14.2% | 14.6% | 4.8% | 14.2% |
Pulmonary Hypertension | 6.6% | 3.5% | 7.5% | 8.7% | 29.5% | 5.5% | 8.3% | 2.1% | 3.8% | 4.9% | 6.9% | 1.1% | 5.8% |
Hypothyroidism | 15.3% | 10.1% | 23.9% | 14.7% | 20.5% | 17.7% | 14.2% | 8.2% | 15.6% | 16.5% | 22.5% | 6.4% | 12.6% |
Renal failure | 23.5% | 11.5% | 13.3% | 10.9% | 17.4% | 14.7% | 37.1% | 11.1% | 11.6% | 20.6% | 23.6% | 4.8% | 39.1% |
Obesity | 15.5% | 15.3% | 13.5% | 14.9% | 7.5% | 15.3% | 21.8% | 11.7% | 23.4% | 11.1% | 11.6% | 14.4% | 12.7% |
Alcohol abuse | 1.7% | 3.5% | 1% | 1.4% | 1.4% | 2.1% | 4.2% | 4.3% | 4.4% | 2.9% | 1.1% | 0.5% | 2.4% |
Drug abuse | 4.9% | 4.9% | 2.5% | 2.5% | 2.6% | 3.2% | 1.7% | 7.5% | 3.6% | 1.8% | 1.1% | 5.3% | 3.5% |
Depression | 15.6% | 14.6% | 17.2% | 12.5% | 13.2% | 15.6% | 10.4% | 10.5% | 17.6% | 10.7% | 13.9% | 14.9% | 11.1% |
Outcomes | |||||||||||||
In-hospital mortality | 1.9% | 2.4% | 2% | 3.5% | 4.8% | 2.3% | 2.4% | 1.3% | 1.4% | 1.1% | 2.6% | 2.1% | 4% |
Length of stay, d, mean ± SD | 5.5 ± 6.9 | 5.5 ± 7.4 | 5.1 ± 6.3 | 6.9 ± 8.7 | 6.2 ± 7.6 | 5 ± 5.4 | 5.4 ± 5.9 | 5.8 ± 6.3 | 4.9 ± 5.6 | 6 ± 6.7 | 4.9 ± 4.6 | 5.8 ± 8.6 | 7.1 ± 8.8 |
Total hospitalization cost, $, mean ± SD | 14389 ± 21148 | 17661 ± 22624 | 14213 ± 19367 | 19190 ± 39030 | 17052 ± 29497 | 13744 ± 16245 | 14566 ± 18344 | 14343 ± 17693 | 14726 ± 18097 | 14742 ± 18924 | 13368 ± 14943 | 16008 ± 25989 | 19874 ± 29132 |
- Citation: Khan MZ, Patel K, Patel KA, Doshi R, Shah V, Adalja D, Waqar Z, Franklin S, Gupta N, Gul MH, Jesani S, Kutalek S, Figueredo V. Burden of atrial fibrillation in patients with rheumatic diseases. World J Clin Cases 2021; 9(14): 3252-3264
- URL: https://www.wjgnet.com/2307-8960/full/v9/i14/3252.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i14.3252